ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium Hydroxide → 1-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-piperazine

HRID 570572
印刷

反応式

HRID 570572 の反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[C:11]([N:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)[S:10][N:9]=2)=[CH:4][CH:3]=1.[CH3:19][O:20][C:21]1[CH:26]=[CH:25][C:24]([CH2:27][C:28]([C:30]2C=CC=CC=2)=O)=[CH:23][CH:22]=1.[BH4-].[Na+].[OH-].[Na+]>C1COCC1.[Ti].CCOC(C)=O.O.CO>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[C:11]([N:13]3[CH2:18][CH2:17][N:16]([CH:28]([CH3:30])[CH2:27][C:24]4[CH:25]=[CH:26][C:21]([O:20][CH3:19])=[CH:22][CH:23]=4)[CH2:15][CH2:14]3)[S:10][N:9]=2)=[CH:4][CH:3]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

10

反応物 4

HCID 14798Sodium HydroxideHCID 2310922-(4-Methoxyphenyl)-1-phenylethan-1-oneHCID 4311764Sodium borohydrideHCID 577122563-(4-Chlorophenyl)-5-(piperazin-1-yl)-1,2,4-thiadiazole

生成物 1

HCID 711864501-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-piperazine

試薬・触媒・溶媒 5

HCID 23963
Titanium
触媒
HCID 887Methanol溶媒
HCID 962Water溶媒
HCID 8028Tetrahydrofuran溶媒
HCID 8857Ethyl Acetate溶媒

実験手順

A mixture of 3-(4-chlorophenyl)-5-(piperazin-1-yl)-1,2,4-thiadiazole (100 mg, 356 μmol), 4-methoxyphenylacetophenone (64.3 mg, 392 μmol) and titanium IV propoxide (152 mg, 158 μl, 534 μmol) in 2 mL THF was stirred for 3 h at RT. NaBH4 (40.4 mg, 1.07 mmol) was added in three portions. MeOH (0.2 mL) was added and stirred over the weekend at RT. Water (5 mL), EtOAc (10 mL) and aq. 2N NaOH (3 mL) was added, stirred for 10 min and filtered over a dicalit-plug. The aqueous layer was separated and extracted once with EtOAc (20 mL). The organic layers were washed with brine (1×20 mL), dried over Na2SO4, filtered off and concentrated in vacuo. The residue was purified by column chromatography on silica eluting with a gradient formed from heptane and EtOAc and again with preparative HPLC to yield, after evaporation of the product containing fraction, 39 mg (25%) of the title compound as off-white solid. MS (m/e): 429.2 (MH+).

後処理

  1. stirringstirred over the weekend at RT
  2. stirringstirred for 10 min
  3. filtrationfiltered over a dicalit-plug
  4. customThe aqueous layer was separated
  5. extractionextracted once with EtOAc (20 mL)
  6. washThe organic layers were washed with brine (1×20 mL)
  7. dry with materialdried over Na2SO4
  8. filtrationfiltered off
  9. concentrationconcentrated in vacuo
  10. customThe residue was purified by column chromatography on silica eluting with a gradient
  11. customformed from heptane and EtOAc and again with preparative HPLC
  12. customto yield
  13. customafter evaporation of the product
  14. additioncontaining fraction, 39 mg (25%) of the title compound as off-white solid

出典と根拠

ORDレコード
ord-a97133ec86884350850eda196d8f8e89
出典データセット
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09023852B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート